ETAR antagonist ZD4054 exhibits additive effects with aromatase inhibitors and fulvestrant in breast cancer therapy, and improves in vivo efficacy of anastrozole
Titel:
ETAR antagonist ZD4054 exhibits additive effects with aromatase inhibitors and fulvestrant in breast cancer therapy, and improves in vivo efficacy of anastrozole
Auteur:
Smollich, Martin Götte, Martin Fischgräbe, Jeanett Macedo, Luciana F. Brodie, Angela Chen, Shiuan Radke, Isabel Kiesel, Ludwig Wülfing, Pia